Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002049562 | SCV002110017 | uncertain significance | Developmental and epileptic encephalopathy, 26 | 2021-05-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg303*) in the KCNB1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 556 amino acid(s) of the KCNB1 protein. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with clinical features of KCNB1-related conditions (Invitae). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV003223730 | SCV003919644 | likely pathogenic | not provided | 2022-10-24 | criteria provided, single submitter | clinical testing | Identified in an individual with motor and speech developmental delay without seizures in the published literature (van der Ven et al., 2021); Nonsense variant predicted to result in protein truncation as the last 556 amino acids are lost; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 34490615, 31957018) |